These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2130661)
1. Evidence for nerve growth factor-ganglioside interaction in forebrain cholinergic neurons. Cuello AC; Garofalo L; Maysinger D Acta Neurobiol Exp (Wars); 1990; 50(4-5):451-60. PubMed ID: 2130661 [TBL] [Abstract][Full Text] [Related]
2. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1. Casamenti F; Milan F; Pepeu G Acta Neurobiol Exp (Wars); 1990; 50(4-5):461-73. PubMed ID: 2130662 [TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats. Garofalo L; Cuello AC Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain. Garofalo L; Cuello AC J Pharmacol Exp Ther; 1995 Feb; 272(2):527-45. PubMed ID: 7853166 [TBL] [Abstract][Full Text] [Related]
5. Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields. Hu L; Côté SL; Cuello AC Exp Neurol; 1997 Jan; 143(1):162-71. PubMed ID: 9000455 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of nerve growth factor-induced alterations in cholinergic fibre length and presynaptic terminal size in cortex of lesioned rats by the monosialoganglioside GM1. Garofalo L; Ribeiro-da-Silva A; Cuello AC Neuroscience; 1993 Nov; 57(1):21-40. PubMed ID: 8278055 [TBL] [Abstract][Full Text] [Related]
7. Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Cuello AC; Garofalo L; Kenigsberg RL; Maysinger D Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2056-60. PubMed ID: 2928318 [TBL] [Abstract][Full Text] [Related]
8. Development of cholinergic pedunculopontine neurons in vitro: comparison with cholinergic septal cells and response to nerve growth factor, ciliary neuronotrophic factor, and retinoic acid. Knusel B; Hefti F J Neurosci Res; 1988; 21(2-4):365-75. PubMed ID: 3216429 [TBL] [Abstract][Full Text] [Related]
9. Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro. Hartikka J; Hefti F J Neurosci Res; 1988; 21(2-4):352-64. PubMed ID: 3216428 [TBL] [Abstract][Full Text] [Related]
10. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain. Mahadik SP; Mukherjee S Biol Psychiatry; 1995 Aug; 38(4):246-54. PubMed ID: 8547447 [TBL] [Abstract][Full Text] [Related]
11. Trophic factor effects on cholinergic innervation in the cerebral cortex of the adult rat brain. Cuello AC; Maysinger D; Garofalo L Mol Neurobiol; 1992; 6(4):451-61. PubMed ID: 1285934 [TBL] [Abstract][Full Text] [Related]
12. Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase and high affinity choline uptake decrease after lesion of the nucleus basalis. Di Patre PL; Casamenti F; Cenni A; Pepeu G Brain Res; 1989 Feb; 480(1-2):219-24. PubMed ID: 2713652 [TBL] [Abstract][Full Text] [Related]
13. Microencapsulated monosialoganglioside GM1: physical properties and in vivo effects. Maysinger D; Jalsenjak V; Stolnik S; Garofalo L; Cuello AC; Jalsenjak I J Microencapsul; 1989; 6(1):35-42. PubMed ID: 2715912 [TBL] [Abstract][Full Text] [Related]
15. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins. Burke MA; Mobley WC; Cho J; Wiegand SJ; Lindsay RM; Mufson EJ; Kordower JH Exp Neurol; 1994 Dec; 130(2):178-95. PubMed ID: 7867749 [TBL] [Abstract][Full Text] [Related]
16. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Gibbs RB Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764 [TBL] [Abstract][Full Text] [Related]
17. Trophic effect of exogenous nerve growth factor on rat striatal cholinergic neurons: comparison between intraparenchymal and intraventricular administration. Venero JL; Hefti F; Knusel B Mol Pharmacol; 1996 Feb; 49(2):303-10. PubMed ID: 8632763 [TBL] [Abstract][Full Text] [Related]
18. Gangliosides and neurotrophic factors in neurodegenerative diseases: from experimental findings to clinical perspectives. Fusco M; Vantini G; Schiavo N; Zanotti A; Zanoni R; Facci L; Skaper SD Ann N Y Acad Sci; 1993 Sep; 695():314-7. PubMed ID: 8239303 [TBL] [Abstract][Full Text] [Related]
19. Does senile impairment of cholinergic system in rats concern only disturbances in cholinergic phenotype or the progressive degeneration of neuronal cell bodies? Niewiadomska G; Wyrzykowska J; Chechłacz M Acta Biochim Pol; 2000; 47(2):313-30. PubMed ID: 11051196 [TBL] [Abstract][Full Text] [Related]
20. Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neocortical infarction. Liberini P; Pioro EP; Maysinger D; Ervin FR; Cuello AC Neuroscience; 1993 Apr; 53(3):625-37. PubMed ID: 8487947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]